Hepatobiliary Surgery Unit, General Surgery Department, Ospedale San Raffaele, Via Olgettina 60, Milano, Italy.
World J Surg. 2013 Jun;37(6):1388-96. doi: 10.1007/s00268-013-1980-2.
The diagnosis and treatment of hilar tumors requires a multidisciplinary approach based on the synergy of radiologists, surgeons, oncologists, and gastroenterologists. Klatskin tumor is a relatively rare disease with a poor prognosis. Currently, the only possible treatment is represented by the removal of the tumor associated with radical surgery, even though its results are still jeopardized by significant morbidity and mortality. A proper preoperative optimization of the patient, including staging laparoscopy, biliary drainage, and portal vein embolization, may improve short-term outcome. The purpose of this study was to evaluate the short- and long-term impact of preoperative optimization in patients affected by hilar cholangiocarcinoma.
From January 2004 to May 2012, 94 patients with preoperative diagnosis of Klastkin tumors were candidates for surgery at the Hepatobiliary Surgery Unit of the Hospital San Raffaele in Milan. The data of all patients were prospectively collected and retrospectively reviewed. The outcome was evaluated in terms of perioperative morbidity and mortality and overall and disease-free survival. Short-term outcome of patients undergoing preoperative optimization was compared with outcome of patients who did not undergo it in terms of intraoperative data, morbidity and mortality.
Of 94 patients undergoing surgery, 80 underwent hepatic and biliary confluence resection. Fourteen patients were considered unresectable due to the presence of peritoneal carcinomatosis or advanced disease seen during staging laparoscopy or at laparotomy and therefore were excluded from the analysis. Seventy-five (93.7 %) patients underwent major liver resections: in 14 of these, surgery was performed at a distance of 30-40 days from PVE. In 55 patients, biliary drainage was preoperatively placed for palliation of obstructive jaundice. The postoperative morbidity rate was 51.2 % and mortality 6.2 %. The most frequent cause of death was postoperative liver failure. Five-year survival rate was 29 %. Patients undergoing preoperative optimization experienced a significant reduction of postoperative morbidity, especially in terms of infectious related events.
Klatskin tumor remains a disease associated with poor prognosis, but a correct preoperative diagnostic and therapeutic management provides tools to perform this type of surgery with acceptable morbidity and mortality, thus improving long-term results.
肝门部肿瘤的诊断和治疗需要多学科的方法,这种方法基于放射科医生、外科医生、肿瘤学家和胃肠病学家的协同作用。KlAtskin 肿瘤是一种相对罕见的疾病,预后不良。目前,唯一可能的治疗方法是切除与根治性手术相关的肿瘤,尽管其结果仍然受到高发病率和死亡率的威胁。对患者进行适当的术前优化,包括分期腹腔镜检查、胆道引流和门静脉栓塞,可能会改善短期结果。本研究的目的是评估术前优化对肝门部胆管癌患者的短期和长期影响。
从 2004 年 1 月至 2012 年 5 月,94 例术前诊断为 KlAtskin 肿瘤的患者在米兰圣拉斐尔医院肝胆外科接受手术治疗。所有患者的数据均进行前瞻性收集和回顾性分析。结果评估了围手术期发病率和死亡率以及总生存率和无病生存率。术前优化患者的短期结果与未行术前优化患者的术中数据、发病率和死亡率进行了比较。
在 94 例接受手术的患者中,80 例接受了肝和胆道汇合部切除术。由于存在腹膜转移或分期腹腔镜检查或剖腹探查时发现的晚期疾病,14 例患者被认为不可切除,因此被排除在分析之外。75 例(93.7%)患者接受了主要肝切除术:其中 14 例在 PVE 后 30-40 天进行手术。在 55 例患者中,术前放置胆道引流以姑息性治疗梗阻性黄疸。术后发病率为 51.2%,死亡率为 6.2%。最常见的死亡原因是术后肝功能衰竭。5 年生存率为 29%。接受术前优化的患者术后发病率显著降低,尤其是在感染相关事件方面。
KlAtskin 肿瘤仍然是一种预后不良的疾病,但正确的术前诊断和治疗管理为进行这种类型的手术提供了工具,可接受的发病率和死亡率,从而改善长期结果。